- Advertisement -
In its latest quarterly activities report, Australian medical cannabis firm Little Green Pharma (ASX:LGP) paints a pretty rosy picture.
For the quarter ending September 2024, the company reported record revenue of $10.2 million (unaudited), which was up 40% on the prior quarter and close to 60%…
